The Lancet kwanan nan ta fitar da kwamitin ta na COVID-19 da aka dade ana jira Rahoton. Rahoton ya nuna da kyau halin da ake ciki na kimiyyar kiwon lafiyar jama'a da kuma magance bukatun kasuwanci na Lancet. Yana iya zama wawanci don tsammanin gaba, amma kiwon lafiya yanki ne mai mahimmanci kuma yakamata a ɗauka da mahimmanci.
Matsayin ɓarna shaida, ɓarnatar da ilimin da ya gabata, da rashin kula da bambance-bambancen shaidar kimiyya da ra'ayi ba su da kyau a kan ko wannensu. Lancet ko kuma ita kanta hukumar.
The Lancet a cikin mahallin
Magunguna da lafiyar jama'a sun dogara ne musamman ga gaskiya da gaskiya, saboda ba za a iya jingina rayuwar mutane da lafiyar mutane ga akida da camfi ba. Muhawara bayyananne da bayyane yana da mahimmanci don rage kurakurai, wanda zai iya kashewa, da kuma haɓaka amanar da marasa lafiya da al'umma ke buƙatar bin jagora (kamar yadda dole ne su zama masu yanke shawara a ƙarshe). Waɗannan tarbiyya guda biyu kuma suna ƙara zama mai hankali ga masu karatu kuma kamfanonin suna samar da kayan abinci da suke aiki. Wadannan dakarun ba makawa suna ja ta hanyoyi daban-daban.
Kamfanoni masu zaman kansu da ke yin waɗannan kayayyaki, kamar waɗanda ke cikin masana'antar magunguna, suna da alhakin haɓaka riba ga masu hannun jarin su. Wannan yana nufin ƙarfafa mutane da yawa su yi amfani da gwaje-gwajensu ko magungunansu, maimakon sanya mutane cikin jihohin lafiya inda ba sa buƙatar su (ko dai lafiya, ko mutuwa).
Wannan ba matsananciyar matsayi ba ne, gaskiya ce mai sauƙi - shine yadda aka tsara wannan masana'antu. Idan akwai wani abu mai ban mamaki a cikin dakin gwaje-gwaje wanda ke magance duk cututtukan rayuwa tare da kashi ɗaya, kuma yana da sauƙin sarrafawa da kwafi, to masana'antar Pharma za ta rushe. Pharma yana da aikin gina kasuwa, ba magani ba.
Bayyana gaskiya da gaskiya, a daya bangaren, na iya nufin shigar da wasu magunguna masu fa'ida sosai ba a buƙata ko ma haɗari; cewa madadin magani mai aminci da arha, wanda a baya akwai don wasu dalilai, zai zama mafi tsada-tasiri da ƙarancin haɗari.
Ba za mu iya tsammanin kamfanoni masu zaman kansu za su bayyana wannan ba, saboda zai lalata ko lalata kudaden shiga (kasuwancinsu). Idan ba su yi ƙoƙarin toshe wani magani da aka sake amfani da shi ba wanda ke jefa jarin nasu cikin haɗari, za su ci amanar masu saka hannun jari. Abin da ya kamata su yi, ga masu zuba jarurruka, shine wuce gona da iri na amfanin nasu, ƙara yawan sha'awar mutane don amfani da su, da gudanar da yakin neman zabe don tabbatar da wannan yanayin ya tsawaita gwargwadon iko. Wannan shi ne abin da kowane kasuwanci na riba yake yi - aikinsu ne. Ba zato ba ne.
Mun daɗe da dogara ga mujallolin likita don yin aiki azaman hanyar samun bayanai daga masu bincike zuwa likitocin likita da jama'a. Wannan kyakkyawan tsari ne idan mujallolin sun kasance masu zaman kansu kuma ma'aikata da masu mujallar suna inganta gaskiya sama da siyasa ko ribar kamfani.
Wannan ya taba faruwa; da Lancet, batun wannan labarin, ya kasance mallakar iyali a dā kuma hakan zai iya riƙe ƙimar Thomas Wakley da zuriyarsa. tsaye da hukumomin lafiya har zuwa 1921. Tun daga lokacin mallakar wasu kamfanoni ne na riba, yanzu wani reshe ne na babban ƙungiyar wallafe-wallafen Dutch, 'Elsevier.'
Elsevier kuma mallakar RELX rukuni ne (a baya a London), babban kamfani mai al'ada jerin na manyan masu saka hannun jari ciki har da BlackRock (da haka babban mai shi Vanguard), Morgan Stanley da Bank of America - jeri iri ɗaya kamar manyan magunguna da kamfanonin fasahar kere-kere wadanda kayayyakinsu Lancet buga akan.
Abin da ke sama bai gaya mana cewa akwai kuskure da gangan ko rashin kuskure ba, kawai rikice-rikice na abubuwan da suka shafi mujallu kamar su. Lancet ya kamata a kiyaye. Lancet ta mallaka na ƙarshe yana da alhakin masu hannun jari don amfani da fayil ɗin kadarorin su don haɓaka dawowa; akan wannan ma'auni kadai Lancet yakamata ya fifita wasu kamfanonin harhada magunguna. Iyakar abin da zai iya tsayawa a hanya shine rashin cancanta daga masu shi, ko ka'idar ɗabi'a wanda ke kimanta masu zuba jari ƙasa da mutunci.
A cikin wannan mahallin, Lancet ta An bincika rikodin waƙa akan COVID-19. A cikin Fabrairu 2020 ya buga manyan wasika akan asalin COVID-19 waɗanda suka yi watsi da manyan rikice-rikice na sha'awa waɗanda kusan duka marubuta an haɗa su a madadin asalin hasashe na lab. Ya buga bayanan zamba a sarari akan hydroxychloroquine waɗanda suke muhimmanci a dakatar da karatun jiyya da wuri.
Rashin ingantaccen magani da wuri ya zama dole don tabbatar da ribar Pharma don magunguna da alluran rigakafin COVID-19 daga baya. Daga baya bayyanar da zamba aka bayyana ta daga baya The Guardian kuma ya kasance daya daga cikin manyan koma baya a tarihin zamani.
a 2022 Lancet buga a mai rauni-shaida ra'ayi bayar da shawarar farkisanci na likitanci; rarrabuwa da takurawa mutane bisa bin ka'idojin magunguna. Lancet ta Babban jagoranci ya kasance ba canzawa ko'ina. Wannan shi ne yanayin da ya dace don fahimtar rahoton na Lancet 'Hukumar' COVID-19.
The Lancet Rahoton Hukumar COVID-19
A tsakiyar 2020 Lancet ya dauki mutane daga bangarori daban-daban na rayuwar jama'a don yin bitar bangarori daban-daban na barkewar COVID-19. Wannan'hukumar(wani babban suna na ƙungiyar da aka taru ta sirri daga kasuwanci mai zaman kansa) masanin tattalin arziki Jeffrey Sachs ne ya jagoranta, wanda ya riga ya fitar da rahoton kwanan nan ta bainar jama'a. tattaunawa akan ƙarshe akan yuwuwar tushen SARS-CoV-2, yana nuna yuwuwar asalin dakin gwaje-gwaje sabanin yaduwar dabba da ɗan adam kai tsaye.
An dakatar da wannan bangare na binciken hukumar tun da wuri lokacin da Sachs ya gano cewa mambobin kwamitin da dama sun sami rikice-rikice na sha'awa da ba a bayyana ba wanda ya kai ga samun kudade don gudanar da bincike-bincike na babban dakin gwaje-gwaje da ake zargi da inganta saurin yaduwar bil'adama. Wasu sun kasance marubuta na farko Lancet asalin wasika.
Takaitaccen Takaitaccen Takaddun Gudanarwa yana ba da hasashen ingancin aikin da zai zo, yana lura da kimanta IHME na "An kiyasta mutuwar mutane miliyan 17 daga COVID-2,"A"adadin wadanda suka mutu” kamar yadda hukumar ta lura, musamman abin mamaki saboda ya fi na WHO kimanta don jimlar mace-mace a duk tsawon lokacin annoba. Wadannan alkaluma na WHO sun hada da duk mace-macen da aka yi ta hanyar kulle-kulle da wadanda aka gano kwayar cutar ta kwatsam. Yana da adadi mai wuyar ganewa, ko da rashin kula da rashin mahallin a nan (kusan duk a ƙarshen tsufa, kuma tare da cututtuka masu tsanani).
Abin ban mamaki, hukumar ta ba da rahoton a cikin babban rubutunta sama da mutane miliyan 2.1 da suka mutu daga zazzabin cizon sauro, tarin fuka da HIV da suka taso daga martanin COVID-19 a cikin 2020 kadai. Koyaya, wannan rashin fahimta ce daga mambobin kwamitin na ainihin kididdigar WHO - WHO ta ba da rahoton mutuwar mutane fiye da 2020 daga waɗannan cututtukan amma ba da yawa ba - kodayake wasu da yawa za su taru cikin shekaru masu zuwa.
Dangane da rashin shigar da hukumar da kanta, rahoton ya ba da shawarar a yi la'akari da hanyoyin daban-daban, la'akari da "gazawar magance rikice-rikice na tsari” don zama mai ba da gudummawa ga tsanani.Sai hukumar ba da gangan ta ba da misali na ɓarna ba a cikin halayenta. Babban Sanarwa na Barrington, batar da shi a matsayin kira don "yaduwar kwayar cutar ba tare da kulawa ba."
Wannan, bisa la’akari da furucin da kansa, dole ne ya zama ƙarya, domin ba dole ba ne hukumar ta karanta sanarwar a cikin shekaru biyun da ta samu. Shin ba su yi la'akari da cewa yana da mahimmanci a tambayi waɗanda suka rubuta ko (fiye da 900,000) suka sa hannu ba? Ko sanarwar ta yi daidai ko a'a, ta kasance a baya Manufar WHO ta tushen shaida. Yin watsi da wannan ba zai yuwu ba don bincike mai tsanani.
Gabaɗaya sakamakon binciken hukumar suna da matukar takaici daga mahangar kimiyya, lafiyar jama'a, da gaskiya mai sauki. Bayyanar rashin sanin ƙa'idodin kiwon lafiyar jama'a da aiki, gami da na World Health Organization (WHO), ƙila ta kasance na gaske, ko ƙila a ƙirƙira ta don jaddada wani labari da aka yi niyya don tallafawa. An ba Lancet ta Rikodin waƙa na COVID-19 da mahimmancin kasuwanci, ƙarshen ba zai zama ba zato ba tsammani, amma abin takaici ne ganin manya a matsayi na tasiri suna samar da takaddar wannan yanayin.
Takaitaccen bincike mai mahimmanci
Rahoton yana da taimako yana ba da sashin 'Mahimman Bincike' shafi uku. Yayin da aka rasa sassan babban jiki kamar su euphemism "halayen zamantakewa" don nuna wariyar zamantakewa, da kuma ɗaukaka "hankali" na gaba daya rashin hankali taken WHO ga alurar riga kafi COVID-19, "Babu wanda ke da aminci har sai kowa ya tsira," gabaɗaya yana ɗaukar ainihin abin da ke cikin duka rubutun. Karanta sauran duk da haka ana ba da shawarar fahimtar yadda tunanin lafiyar jama'a na zamani ya fita a fili.
Abubuwan da aka gano sun shiga cikin nan. Duk wanda ke da ilimin kiwon lafiyar jama'a ana ƙarfafa shi ya karyata abubuwan da aka taso, saboda yawancin ikirari na hukumar sun haɗa da tarko na gama gari waɗanda ke da alama ba za su iya ba da uzuri ga kwararrun kiwon lafiyar jama'a ba. Sun rataya sosai kan gazawar fahimtar mahimman abubuwa guda uku na COVID-19 da lafiyar jama'a:
- Ayyukan kiwon lafiyar jama'a suna game da haɗari da fa'ida. Shisshigi yana da tasiri mai kyau da mara kyau. Don haka ba za a iya ba da shawarwari ba tare da la'akari da illar da za su iya haifarwa cikin ɗan gajeren lokaci da dogon lokaci ba, tare da auna waɗannan da fa'idodin da ake gani.
- Yawan mace-macen COVID-19 ya karkata sosai zuwa ga sosai tsufa, kuma suna da alaƙa sosai rikice-rikice. Don haka yana da mahimmanci a yi la'akari da nauyin cutar COVID-19 dangane da wasu cututtuka cikin sharuddan shekaru sun rasa, ba ɗanyen mace-mace ba (daga ko tare da) COVID-19.
- Tsawon kulle-kulle, wuraren aiki da rufe makarantu ba sa cikin kafin manufofin, ko kuma an ba da shawarar wani yanki kawai a cikin nisa mafi tsanani barkewar cutar. Wannan ba yana nuna cewa ayyukan sun yi kyau ko mara kyau ba, kawai gaskiyar cewa sun bijirewa ka'idojin kiwon lafiyar jama'a da shaidar da ta gabata. An ba da shawarar su a kan su saboda cutarwar da ka iya haifarwa. Wannan ƙasa mafi nauyi, kamar yadda WHO ta lura, akan mutane masu karamin karfi da yawan jama'a.
Manyan abubuwan da hukumar ta fitar:
"WHO ta yi taka-tsan-tsan da a hankali a kan wasu muhimman al'amura: … ayyana dokar ta-baci ta lafiyar jama'a… ta hana tafiya… ta amince da amfani da abin rufe fuska…
Da alama hukumar ba ta san ka'idar cutar mura ta WHO a baya ba. Ba ya cikin 499 na su nassoshi. WHO ta yi gargaɗi musamman game da hana tafiye-tafiye a cikin wannan ƙa'idar, tare da lura da cewa shaida kan abin rufe fuska "rauni ne." Hana tafiye-tafiye na iya zama babbar illa ga tattalin arziƙin – yanke kuɗin shiga yawon buɗe ido kaɗai a cikin ƙasashe masu karamin karfi na iya ƙara mace-macen ta hanyar talauci. Rahoton ya kasa ambaton farashin da tsawaita waɗannan matakan mayar da martani zai haifar. Inda aka ambaci farashin kullewa kwata-kwata, yana cikin mahallin halin kuɗaɗen 'kasa' aiwatarwa a baya ko sama da haka, ba a taɓa yin la'akari da cutar da aka kauce wa abin da ya haifar ba. Yin watsi da farashin dangi, gami da tsadar lafiya na dogon lokaci na karuwar talauci daga dogon kulle-kulle, abin kunya ne ga kyakkyawar manufar lafiyar jama'a.
Metanalysis of bazuwar iko gwaji na al'umma masking kar a nuna fa'ida mai mahimmanci, da gwaji yayin nunin COVID-19 irin wannan sakamakon. Aƙalla, WHO ta kasance tushen shaida lokacin da take ba da shawarar a kan abin rufe fuska ga al'umma - har yanzu ƙungiyar ba ta ba da shaidar da za ta goyi bayan amincewarta daga baya na amfani da su ba. The Lancet Hukumar da alama tana ba da shawarar musamman game da amfani da hanyoyin da suka dogara da shaida.
"Mafi yawan gwamnatoci a duniya sun yi jinkirin amincewa da mahimmancinta kuma suyi aiki cikin gaggawa don mayar da martani…."
Yawancin mutane suna rayuwa ne a cikin ƙasashe masu ƙarancin kuɗi da matsakaitan masu samun ƙarancin mace-mace na COVID-19 da nauyi mai yawa daga wasu cututtuka, wanda ke faruwa a cikin matasa masu nisa. Don haka wannan magana da alama tana da ban al'ajabi ga ƙasashen yamma. Idan da sun sani tun da farko, me kasashe za su yi a zahiri? (idan a baya aiwatar da martanin da ke haifar da talauci, to sai yaushe?)
Hukumar ta bayyana ba ta da masaniya game da shaidar serological na yaduwa kafin Janairu 2020, a wasu lokuta goyon bayan PCR. Wannan zai kawar da duk wani fa'ida daga wannan shawarar, har ma da yin watsi da illolin.
Yin la'akari da Yankin Yammacin Pasifik a matsayin misali na 'kulle-kulle aiki' irin wannan hankali kadan, kamar yadda kwatancen sauran wurare (misali Turai) bai nuna ba gagarumin amfani, yayin da jama'a suke yankunan marasa galihu ba su da ma'ana a fili. Shaidar watsawa da wuri (misali Japan) ya nuna cewa ƙarancin mace-mace ya kasance saboda wasu dalilai.
"An dakile yaduwar cutar ta hanyar adawa da jama'a na yau da kullun ga matakan kiwon lafiyar jama'a da na zamantakewa, kamar sanya abin rufe fuska da kyau da kuma yin rigakafin."
Wannan magana jahilci ce ko rashin fahimta. Idan membobin hukumar suna da gogewa game da lafiyar jama'a, sun san cewa keɓancewar mutane masu lafiya, daɗaɗɗen' nesantar aiki da rufe wuraren aiki ba a taɓa yin amfani da su daidai gwargwado ba, da kuma kulle-kulle. ba 'matakan lafiyar jama'a na yau da kullun da zamantakewa.' Idan ba su san wannan ba, sun sami shekaru biyu don ganowa. Duniya, duk da Lancet, ya sani a watan Maris 2020 cewa COVID-19 yana kai hari ga tsofaffi kuma ba shi da wani tasiri ga tsofaffi masu shekaru masu aiki.
Alurar riga kafi ba sa rage yawan yaɗuwar gabaɗaya - ƙasashen da ke da allurar rigakafi suna ci gaba da nuna yaɗuwar cutar - don haka don ba da shawarar ƙarancin rigakafin hana yaduwar cutar wata sanarwa ce. Yana iya zama kamar mai hankali (misali yana faruwa tare da wasu alluran rigakafi) amma hukumar tana da watanni 18 don kiyaye yawan rigakafin COVID-19.
"Manufofin jama'a kuma sun kasa yin amfani da ilimin halayya da zamantakewa."
Wannan sanarwa ce ta ban mamaki don amfani game da COVID-19. Yawancin gwamnatocin Yamma sun yi aiki a fili ilimin halin halayya a cikin hanyar da ba a taɓa yin irinsa ba a cikin annobar COVID-19. Babu wani yaƙin neman zaɓe na lafiyar jama'a da ya taɓa samun irin wannan kulawar kafofin watsa labarai ko kuma aka hana saƙon da ba na hukuma ba daga gidajen yaɗa labarai. Abin mamaki ne ka ga an kawar da wata magana daga gaskiya.
"Ƙungiyoyin da ke da nauyi mai nauyi sun haɗa da ma'aikata masu mahimmanci, waɗanda suka riga sun mai da hankali sosai a cikin ƙananan ƙananan marasa ƙarfi da masu karamin karfi."
Wannan yana nuna alamar jin kai ga jama'a masu rauni. Gaskiya ne cewa wasu ƙungiyoyi sun sha wahala mafi girma na COVID-19 mai tsanani, kodayake waɗannan suna da alaƙa sosai da ƙimar cututtuka (kiba a cikin ƙasashen Yamma abin takaici yana da alaƙa da talauci, da talauci tare da wasu kabilu).
Duk da haka, nauyin ya kasance mai yawa a kan tsofaffi - zuwa adadi dubbai da yawa sau da cewa a cikin matasa. Amsar ita ce ta dora wa waɗannan ƙungiyoyin nauyi a sarari kuma rahoton ya ambaci rufe makarantu na rashin adalci, amma wannan ya bayyana an manta da shi a wani wuri a cikin alamun tallafin makaho don saurin kullewa.
"A cikin ƙananan kuɗi da ƙasashe masu matsakaicin kuɗi (LMICs)… an sami sakamako mafi kyau lokacin da aka gina abubuwan da suka faru a baya game da barkewar annoba da annoba, da kuma lokacin da aka yi amfani da albarkatun al'umma-musamman ma'aikatan kiwon lafiya na al'umma - don tallafawa bincike da tuntuɓar ganowa, iyawa da gina aminci tsakanin al'ummomi."
Wannan da'awar ta bayyana karya. Kasashen Afirka da ke kudu da hamadar Sahara sun yi kyau ba tare da la'akari da gogewar da suka yi a baya ba, ban da Afirka ta Kudu inda kiba ya fi yawa kuma akwai adadi mafi girma na tsofaffi. Tanzaniya ta ƙaddamar da takamaiman matakan COVID-19 kaɗan amma yana da sakamako iri ɗaya. Fiye da rabin mutanen kudu da hamadar sahara ne kasa da 20 shekaru masu shekaru, rukuni-rukuni masu ƙarancin mace-mace a Yamma. Yaduwar gaske a Afirka, WHO ta tabbatar, ya kasance mai girma sosai.
"...tallafin samar da alluran rigakafi a cikin LMICs, don amfani da su a cikin waɗannan ƙasashe, ya zo da tsada sosai dangane da rashin daidaiton damar yin rigakafin."
Kusan dukkan mutane a kasashe masu karamin karfi da matsakaicin kudin shiga (sai dai China) za su iya zuwa yanzu da immunity. Maganin rigakafi bayan kamuwa da cuta daidai yake ko mafi inganci zuwa rigakafin rigakafin da aka haifar. Don haka, yawan allurar rigakafin cutar COVID-19 na jama'a da yawa waɗanda ba su rage yawan watsawa ba ba zai iya ba da fa'ida sosai ba, yayin da karkatar da albarkatu na da illa. Don haka wannan magana ba ta da hankalin lafiyar jama'a.
"Fara da tattalin arziki ya dogara da dorewar yawan adadin allurar rigakafin..."
Farfado da tattalin arziki ya dogara da cire cikas ga tattalin arzikin mai aiki (matakan kullewa). Alurar riga kafi da rigakafin da ba ya daina watsawa ba zai iya taimakawa wajen 'sake buɗe' tattalin arziki ba. Wannan bayanin yana ɗaukar saƙon allurar rigakafi na hukuma a wani wuri, amma Lancet ta Hukumar ta sami damar haɓaka dabaru da manufofin tushen shaida.
"Tsarin ci gaba mai ɗorewa ya koma baya shekaru da yawa, tare da zurfafa zurfafan kuɗaɗen zuba jari da ake buƙata don cimma burin ci gaba mai dorewa."
Lallai wannan a fili yake. Talauci ya fi muni, rashin abinci mai gina jiki ya fi muni, kuma nauyin cututtuka da za a iya rigakafin su ya fi yawa. Ana rage yancin mata a duk faɗin duniya, kuma an hana zuwa makaranta ga ɗaruruwan miliyoyin yara, wanda ke haifar da talauci a nan gaba. Yarda da wannan yana da mahimmanci, amma kuma yana sanya ayar tambaya da yawa daga cikin ragowar rahoton. Shawarwari waɗanda suka yarda da waɗannan illoli masu yawa waɗanda aka mayar da hankali kan yawan jama'a masu ƙarancin haɗarin COVID-19, amma sun ci gaba da ba da shawarar ƙarin ayyukan da suka haifar da su, da alama ba a yi la'akari da su sosai ba.
Sauran mahimman binciken sun ba da shawarar manufofin yawan allurar rigakafin 'don kare yawan jama'a,' ƙarin kuɗi don Hukumar Lafiya ta Duniya, da ƙarin kuɗi na duniya don masu goyon bayan ci gaban ajanda. Wannan wasa zuwa Lancet ta gallery, amma baya la'akari da illolin karkatar da albarkatu, ainihin ƙananan mace-mace daga annoba a cikin shekaru 100 da suka gabata, ko bambancin yawan jama'a da haɗarin cututtuka.
Idan alluran rigakafin sun yi aiki wajen rage mace-mace (don mace-mace duka (da Pfizer da kuma Moderana Gwaje-gwajen da bazuwar ba su nuna wannan ba har zuwa yau), idan an killace allurar ga ƙungiyoyi masu rauni sosai inda za a iya samun fa'ida, kuma idan an kashe tiriliyan daloli don biyan diyya, gwajin jama'a da yawan allurar rigakafin cutar kan cutar cututtukan da ke fama da cutar da rage talauci, shin da gaske Hukumar ta yi imani da ƙarin mutane za su mutu kuma sakamakon ya yi muni?
Rashin lafiyar jama'a da kimiyya
Da alama mambobin hukumar sun gamsu cewa kulle-kulle da yin alluran rigakafi ba su da amfani sosai, amma kuma ya nuna cewa a cikin shekaru biyu na shawarwarin ba su yi la'akari da madadin ba. Asarar ci gaban shekaru masu yawa akan cututtuka masu yaduwa, 'yancin ɗan adam, da rage talauci da ke haifar da kulle-kulle bai ba da isasshen lokacin tunani ba.
Kwayar cutar da ta fi shafa mutane sama da shekaru 75 an magance ta tare da mayar da martani ga lafiyar jama'a wanda ke kaiwa yara da masu samar da tattalin arziki, da ke tabbatar da talauci da rashin adalci na dogon lokaci. Suna goyon bayan wannan tsarin, amma suna la'akari da cewa ya kamata a kafa shi a baya, kuma an dauke shi da sauri.
Bayan jaddada ma'auni na wajibi da ƙuntatawa a ko'ina, da kuma ɓarna ko watsi da wasu hanyoyin, rahoton ya ƙare da bayanin da ya kamata a fara da shi. "Mun lura da daidai lokacin da aka sake mayar da hankali kan Yarjejeniya ta Duniya ta Hakkokin Dan Adam, ka'idojin ɗabi'a na Majalisar Dinkin Duniya, yayin da muke bikin cika shekaru 75 a 2023. "
wannan sanarwar ya haɗa da haƙƙin yin aiki, tafiye-tafiye, zamantakewa, da bayyana ra'ayi cikin 'yanci gami da, musamman, ta kowace kafofin watsa labarai. A sauri karanta na Dokar WHO zai kuma taimaka - kiwon lafiya ya haɗa da jin daɗin zamantakewa da tunani (da kuma jin daɗin jiki fiye da wata cuta guda). Rahoton ba shi da irin wannan tunani - cin mutuncin 'yancin ɗan adam da lafiyar jama'a.
Da ma an rubuta rahoton bisa taken daga WHO, gavi da kuma CEPI (wanda Lancet ya ba da shawarar ya kamata ya sami ƙarin kuɗi), daga kamfanonin Pharma (akan tallafin su Lancet dogara sosai kai tsaye ko a kaikaice) kuma daga Tattalin Arziki na Duniya (wanda ya zama kamar ko'ina a kwanakin nan).
Wasu za su yi fatan yin hankali da yin la'akari da tunani, faɗaɗa shawara, da tushe mai ƙarfi. Da alama duniyar kamfanoni na iya daina samun lokaci don irin wannan sha'awar. Wannan shine, a ƙarshe, ƙungiyar masu kuɗi, suna neman ƙarin tallafin masu biyan haraji don aikin da suka fi so. Suna yin haka ne da sunan lafiyar al’umma.
Ya dace a yi fatan alheri. Menene Thomas Wakley zai yi tunani?
-
David Bell, Babban Masanin Kimiyya a Cibiyar Brownstone, likitan lafiyar jama'a ne kuma mai ba da shawara kan ilimin halittu a cikin lafiyar duniya. David tsohon jami'in kiwon lafiya ne kuma masanin kimiyya a Hukumar Lafiya ta Duniya (WHO), Shugaban Shirin Malaria da cututtukan zazzabi a Gidauniyar Innovative New Diagnostics (FIND) a Geneva, Switzerland, kuma Daraktan Fasahar Kiwon Lafiya ta Duniya a Asusun Kula da Lafiya na Duniya na Intellectual Ventures a Bellevue, WA, Amurka.
Duba dukkan posts
